Sonex Health

Sonex Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $50M

Overview

Sonex Health is a private medical device company pioneering in-office, minimally invasive hand surgery using real-time ultrasound guidance. Its flagship platform, UltraGuideCTR™, enables carpal tunnel release procedures under local anesthesia, with over 43,000 procedures completed, demonstrating rapid patient recovery and strong clinical outcomes. The company complements its device business with a robust educational arm, The Institute of Advanced Ultrasound Guided Procedures, which trains physicians on musculoskeletal ultrasound techniques. Sonex Health is positioned in the large and growing market for minimally invasive alternatives to traditional open and endoscopic hand surgeries.

MusculoskeletalNeurological

Technology Platform

Proprietary real-time ultrasound guidance platform for minimally invasive hand surgery, enabling visualization of anatomy during procedures like carpal tunnel and trigger finger release.

Funding History

2
Total raised:$50M
Series B$30M
Series A$20M

Opportunities

The large and growing patient population with carpal tunnel syndrome and trigger finger, combined with the healthcare industry's strong push towards lower-cost, in-office procedures, presents a major expansion opportunity.
Further opportunities exist in applying the ultrasound-guided platform to other common musculoskeletal conditions, expanding the company's total addressable market.

Risk Factors

Key risks include competition from established surgical methods and new entrants, the challenge of securing consistent insurance reimbursement for in-office procedures, and the adoption barrier posed by the need for extensive physician training in a new technique.

Competitive Landscape

Sonex Health competes with traditional open and endoscopic carpal tunnel release instrument manufacturers (e.g., Integra LifeSciences, Stryker). It also faces potential competition from other companies developing minimally invasive or needle-based release technologies. Its integrated device-and-education model creates a unique competitive position focused on enabling a shift in the standard of care.